Resources Contact Us Home
Recombinant toxin fragments

Image Number 4 for United States Patent #8017134.

A single polypeptide is provided which comprises first and second domains. The first domain enables the polypeptide to cleave one or more vesicle or plasma-membrane associated proteins essential to exocytosis, and the second domain enables the polypeptide to be translocated into a target cell or increases the solubility of the polypeptide, or both. The polypeptide thus combines useful properties of a clostridial toxin, such as a botulinum or tetanus toxin, without the toxicity associated with the natural molecule. The polypeptide can also contain a third domain that targets it to a specific cell, rendering the polypeptide useful in inhibition of exocytosis in target cells. Fusion proteins comprising the polypeptide, nucleic acids encoding the polypeptide and methods of making the polypeptide are also provided. Controlled activation of the polypeptide is possible and the polypeptide can be incorporated into vaccines and toxin assays.

  Recently Added Patents
Release layer
Electronic communication device
Large scale data storage system with fault tolerance
Display apparatus, control method thereof, and program
Automatically selecting a paper with increased dimensions than originally desired for printing and adding advertisement content to the increased dimensional area of the paper
Method for providing information of access point selection
Differentiated PSIP table update interval technology
  Randomly Featured Patents
Self-adjusting weatherstrip
Barbecue stand
Method for cooling using impinging jet control
Hybrid stent and method of making such a stent
Optical RF signal processing
Use of cells containing a specific DNA molecule as cytopathic agents to inhibit the proliferation of cells
Heat sink mounting systems and methods
Method of manufacturing a semiconductor device including a mosfet with nitride sidewalls
Nerve identification method
Adaptive multitone signaling method